Galactose metabolites in blood from neonates with and without hypergalactosaemia detected by mass screening

2000 ◽  
Vol 159 (11) ◽  
pp. 851-853 ◽  
Author(s):  
Nobuyuki Mizoguchi ◽  
Hiroaki Ono ◽  
Takaatsu Eguchi ◽  
Nobuo Sakura
Keyword(s):  
Mass Screening ◽  
Galactose Metabolites

Transient galactosemia detected by neonatal mass screening

1999 ◽  
Vol 41 (3) ◽  
pp. 281-284 ◽  
Author(s):  
HIROAKI Ono ◽  
HIDEO Mawatari ◽  
NOBUYUKI Mizoguchi ◽  
TAKAATSU Eguchi ◽  
Nobuo Sakura1 and Mochiyuki Hamakawa
Keyword(s):  
Mass Screening

The Concepts of Prevalence and Incidence as Applied to the Study of Development and Duration of Disease

1968 ◽  
Vol 7 (02) ◽  
pp. 111-117 ◽  
Author(s):  
M. Kashgahian
Keyword(s):  
Mass Screening ◽  
Disease Process ◽  
Incidence Data ◽  
Disease States ◽  
History Of ◽  
Duration Of Disease ◽  
Process Methodology

The proper use of prevalence and incidence data can result in an effective way to study the history of the disease process. Methodology is given whereby the progression, duration and transition of diseases can be elucidated. Prevalence and incidence have been redefined and used in an unconventional way in view of new types of data which are being generated by mass screening projects for disease which are able to discover presymptomatic and preclinical disease states.

EVALUATION OF MASS SCREENING FOR BREAST CANCER

1992 ◽  
Vol 42 (3) ◽  
pp. 261-272
Author(s):  
TSUNEHIRO ISHIDA ◽  
TAKAO YOKOE ◽  
YUICHI IINO ◽  
TETSUO OGAWA ◽  
TOSHIKAZU ISHIKITA ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Mass Screening

Shifting from nasopharyngeal swab to sputum for mass screening of COVID-19 patients in India- A public health perspective

2020 ◽  
Vol 23 (19) ◽  
Author(s):  
Nishantadeb Ghatak ◽  
Sheikh Mohd Saleem ◽  
Roy Rillera Marzo ◽  
Sudip Bhattacharya ◽  
Amarjeet Singh
Keyword(s):  
Public Health ◽  
Mass Screening ◽  
Nasopharyngeal Swab ◽  
Public Health Perspective

PROSPECTS OF ARTIFICIAL INTELLIGENCE IN CARRYING OUT THE ONCOLOGICAL COMPONENT OF MEDICAL EXAMINATION OF THE POPULATION

2019 ◽  
Vol 65 (2) ◽  
pp. 234-237
Author(s):  
Vyacheslav Cherenkov ◽  
A. Petrov ◽  
I. Gulkov ◽  
A. Kostyukov
Keyword(s):  
Artificial Intelligence ◽  
Early Diagnosis ◽  
Mass Screening ◽  
Malignant Tumors ◽  
Risk Groups ◽  
Modern World ◽  
Pilot Program ◽  
Urgent Problem ◽  
Gender And Age ◽  
Group Version

Diagnosis of malignant tumors is an urgent problem of the modern world. Early diagnosis depends on General practitioners. The doctor should conduct a systematic examination of the patient regularly, taking into account the risk groups, gender and age. With mass screening, signs of dysplasia or an early focus, developing cancer can «slip away» [1]. Optimization of analysis and examination algorithms is required, which is not always possible for one person. Positive application of the digital program with elements of imaging in Oncology, we were able to create such a class of tasks for the preliminary subjective-objective survey of patients in three versions: with a widescreen screen and consoles for patients (group version up to 15 or more patients), interactive (touch) and tablet. The results of the survey are sent through the accepted channels to the doctor with recommendations for further examination, and the patient is given a coupon. The pilot program showed that the system of such robotic technologies in the future can replace the oncologist in its development to artificial intelligence at the stage of the primary link.

A Novel Strategy for SARS-CoV-2 Mass-Screening Using Quantitative Antigen Testing of Saliva

2020 ◽  
Author(s):  
Isao Yokota ◽  
Peter Y. Shane ◽  
Kazufumi Okada ◽  
Yokota Unoki ◽  
Yichi Yang ◽  
...  
Keyword(s):  
Mass Screening ◽  
Novel Strategy ◽  
Antigen Testing
Sign in / Sign up

Export Citation Format

Share Document